Efficacy and safety of Qinzhuliangxue decoction for treating atopic eczema: a randomized controlled trial | Zendy

Tian Ma | Zendy; Yuanyuan Chai | Zendy; Li Su | Zendy; Xiaoying Sun | Zendy; Yifei Wang | Zendy; Rong Xu | Zendy; Jie Chen | Zendy; Mi Zhou | Zendy; Min Zhou | Zendy; Bin Li | Zendy; Wenbin Xu | Zendy; Xin Li | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy and safety of Qinzhuliangxue decoction for treating atopic eczema: a randomized controlled trial

Author(s) -

Tian Ma,

Yuanyuan Chai,

Li Su,

Xiaoying Sun,

Yifei Wang,

Rong Xu,

Jie Chen,

Mi Zhou,

Min Zhou,

Bin Li,

Wenbin Xu,

Xin Li

Publication year - 2020

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.546

H-Index - 19

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm.2020.04.17

Subject(s) - medicine , itching , atopic dermatitis , eczema area and severity index , dermatology life quality index , dermatology , erythema , adverse effect , randomized controlled trial , cure rate , incidence (geometry) , traditional chinese medicine , decoction , alternative medicine , physics , pathology , optics , psoriasis

Atopic eczema is the most common type of skin disorder in both children and adults. It is characterized by erythema, pruritus, papules, xeransis, and lichenification. Qinzhuliangxue decoction (QZLXD), a Chinese herbal medicine (CHM) prepared with several ingredients that are used to treat eczema, was formulated according to the traditional Chinese medicine (TCM) theory. This study aimed to investigate the efficacy and safety of QZLXD administration for treating atopic eczema compared to those of Runzaozhiyang capsules (RZZYC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research